These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 17609444)

  • 1. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
    Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
    J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Transarterial Chemoembolization Combined with CT-Guided Radiofrequency Ablation for Hepatocellular Carcinoma Adjacent to the Hepatic Hilum within Milan Criteria.
    Guo Y; Zhang Y; Huang J; Chen X; Huang W; Shan H; Zhu K
    J Vasc Interv Radiol; 2016 Apr; 27(4):487-95. PubMed ID: 26922006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy.
    Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K
    AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma in the caudate lobe.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Yamakado K
    J Vasc Interv Radiol; 2012 Dec; 23(12):1622-8. PubMed ID: 23177108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
    Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
    Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completeness of treatment in hepatocellular carcinomas treated with image-guided tumor therapies: Evaluation of positive predictive value of contrast-enhanced CT with histopathologic correlation in the explanted liver specimen.
    Kim YS; Rhim H; Lim HK; Park CK; Lee WJ; Do YS; Cho JW
    J Comput Assist Tomogr; 2006; 30(4):578-82. PubMed ID: 16845287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma.
    Yin X; Zhang L; Wang YH; Zhang BH; Gan YH; Ge NL; Chen Y; Li LX; Ren ZG
    BMC Cancer; 2014 Nov; 14():849. PubMed ID: 25409554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation.
    Song KD; Lee MW; Rhim H; Kim YS; Kang TW; Shin SW; Cho SK
    AJR Am J Roentgenol; 2016 Nov; 207(5):1122-1127. PubMed ID: 27575338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
    Park Y; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
    AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.
    Yamanaka T; Yamakado K; Takaki H; Nakatsuka A; Shiraki K; Hasegawa H; Takei Y; Takeda K
    Jpn J Radiol; 2012 Aug; 30(7):553-9. PubMed ID: 22610876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A; Iezzi R; Giuliante F; Salvatore L; Mele C; Posa A; Ardito F; De Gaetano AM; Pompili M;
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.
    Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS
    Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival with up to 10-year follow-up after combination therapy of chemoembolization and radiofrequency ablation for the treatment of hepatocellular carcinoma: single-center experience.
    Fujimori M; Takaki H; Nakatsuka A; Uraki J; Yamanaka T; Hasegawa T; Shiraki K; Takei Y; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 May; 24(5):655-66. PubMed ID: 23428356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.